Autologous stem cell transplantation in an outpatient basis. Analysis of feasibility in the Hospital Clínic of Barcelona, Spain;Trasplante autogénico de progenitores hemopoyéticos en régimen ambulatorio: Análisis de viabilidad en el Hospital Clínic de Barcelona

Medicina Clinica

Volumn 113, Issue 6, 1999, Pages 201-204

  Rives, Susana ^a   Carreras, Enric ^a,b   Rovira, Montserrat ^a   Montoto, Silvia ^a   Urbano Ispizua, Álvaro ^a   Martínez, Carmen ^a   Perales, María ^a   Álvarez, Alberto ^a   Esteve, Jordi ^a   González, Manel ^a   Montserrat, Emili ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Autologous stem cell transplantation; Feasibility; Outpatient

Indexed keywords

ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; AUTOTRANSPLANTATION; BLOOD DISEASE; COMPARATIVE STUDY; FEASIBILITY STUDY; FEMALE; GAS MASK; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL READMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; METHODOLOGY; MICROCLIMATE; MIDDLE AGED; SPAIN; STATISTICS;

ADOLESCENT; ADULT; AMBULATORY CARE; ENVIRONMENT, CONTROLLED; FEASIBILITY STUDIES; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; RESPIRATORY PROTECTIVE DEVICES; SPAIN; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 0347758978     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rozman C, Carreras E, Sierra J, Rovira M, Urbano-Ispizua A, Marín P et al. Trasplante de progenitores hemopoyéticos: 20 años de experiencia en la Escuela de Hematología Farreras Valenti/Hospital Clínic de Barcelona. Med Clin (Barc) 1997; 108: 681-686.
2. Horowitz MM, Rowlings PA. An update from the International Marrow Transplant Registry and the Autologous Blood and Marrow Trasplant Registry on current activity in hematopoietic stem cell transplantation. Curr Opin Hematol 1997; 4: 395-400.
3. Peters WP, Ross M, Vredenburgh JJ, Hussein A, Rubin P, Dukelow K et al. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Semin Oncol 1994; 21: 25-31.
4. Glück S, Des Rochers C, Cano C, Dorreen M, Gill K, López P et al. High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approach. Bone Marrow Transplant 1997; 20: 431-434.
5. Jagannath S, Vesole DH, Zhang M, Desikan KR, Copeland N, Jagannath M et al. Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma. Bone Marrow Transplant 1997; 20: 445-450.
6. Meisengerg BR, Miller WE, McMillan R, Collaghan M, Sloan C, Brehm T et al. Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies. J Clin Oncol 1997; 15: 11-17.
7. Lawrence CC, Gilbert CJ, Peters WP. Evaluation of symptom distress in a bone marrow transplant outpatient environement. Ann Pharmacother 1996; 30: 941-945.
8. Meisenberg BR, Ferran K, Hollenbach K, Brehm T, Jollon J, Piro LD. Reduced charges and costs associated with outpatient autologous stem cell transplantation. Bone Marrow Transplant 1998; 21: 927-932.
9. Manasanch L, Carreras E, Montserrat E. Coste económico del trasplante autólogo de progenitores hematopoyéticos [carta]. Med Clin (Barc) 1997; 108: 558.
10. Juliá A, Bueno J, Gadea N, Masuet D, Del Baño C. Estudio económico del coste del autotrasplante de precursores hemopoyéticos de sangre periférica comparado con el de médula ósea. Med Clin (Barc) 1995; 105: 131-135.
11. De Arriba F, Heras I, García MC, Moraleda JM, Funes C, Ferrer F et al. Coste económico del autotrasplante de progenitores hemopoyéticos. Med Clin (Barc) 1996; 106: 329-332.